Molecular and Biomarker applications
Molecular and biomarker analyses provide deep mechanistic insights into immune responses, disease pathways, and therapeutic effects. At Redoxis, we combine quantitative cytokine profiling, gene expression analysis, protein characterization, histology, and transcriptomics to deliver a comprehensive molecular understanding of your compound’s mechanism of action.
Our platforms are fully integrated with our in vivo, in vitro, and ex vivo models, enabling multi-layered data collection from the same samples and supporting translational decision-making throughout preclinical development.
Cytokine and Chemokine Profiling
Quantitative measurement of soluble immune mediators
Cytokines and chemokines are key biomarkers of immune activation and regulation. Redoxis provides sensitive, multiplexed, and highly reproducible detection of soluble mediators in serum, plasma, tissue homogenates, culture supernatants, and sorted immune cell populations.
What we measure
-
Pro-inflammatory cytokines (e.g., IL-1β, IL-6, TNF-α, IFN-γ)
-
Anti-inflammatory mediators (e.g., IL-10, TGF-β)
-
Chemokines relevant to immune recruitment
-
Toxicity-related biomarkers
Technologies
-
Luminex multiplex analysis
-
ELISA
-
FluoroSpot / ELISpot (single-cell cytokine secretion)
Applications
-
Mechanism-of-action profiling
-
Biomarker discovery
-
Cytokine storm and toxicity risk assessment
-
Immune monitoring in in vivo studies
Gene Expression Analysis (qPCR and ddPCR)
High-sensitivity analysis of gene regulation and pathway modulation
Gene expression analysis is a cornerstone for understanding molecular responses and transcriptional regulation. Redoxis offers complete workflows — from tissue homogenization to data-ready results — using qPCR and droplet digital PCR (ddPCR).
Capabilities
-
Tissue homogenization and RNA extraction
-
Reverse transcription and amplification
-
Absolute quantification via ddPCR
-
Targeted pathway analysis via qPCR
What we measure
-
Transcription factors (e.g., T-bet, RORγt, FoxP3, GATA3)
-
Cytokine and chemokine gene expression
-
Inflammasome-related genes (e.g., NLRP3, IL1B, CASP1)
-
Signaling pathway genes (NF-κB, JAK-STAT, MAPK, etc.)
Applications
-
Mechanism-of-action studies
-
Pathway modulation by therapeutics
-
In vivo tissue profiling
-
Validation of flow cytometry or protein-level findings
Transcriptomics (RNA Sequencing)
Unbiased or targeted analysis of gene expression at bulk or single-cell level
Redoxis offers both bulk RNA-seq and single-cell RNA-seq to provide high-resolution molecular insights.
Single-Cell RNA-seq
What it enables
-
Cell-type-specific transcriptional profiling
-
Characterization of cellular heterogeneity
-
Identification of rare or treatment-responsive subsets
-
Immune repertoire changes (optional)
Ideal for:
-
CNS inflammation, MS, IBD, oncology
-
Heterogeneous immune responses
-
ATMP and biologics characterization
Bulk RNA-seq
What it enables
-
Whole-transcriptome profiling
-
Differential gene expression (DGE) analyses
-
Pathway and network analysis
-
Low-input or sorted-cell applications
Ideal for:
-
Tissue samples, cultured cells, purified populations
-
Biomarker discovery
-
Mechanistic pathway interrogation
Protein Expression and Signaling (Western Blot)
Quantifying protein levels, phosphorylation, and pathway activation
Western blotting provides detailed protein-level confirmation of molecular mechanisms.
What we measure
-
Total protein expression
-
Phospho-protein levels (signaling activation)
-
Biomarker validation
-
Pathway-specific targets (NF-κB, ERK, STAT, AKT, etc.)
Applications
-
Kinase inhibitor profiling
-
Validation of gene expression changes
-
Mechanistic studies in inflammation and oncology
ELISpot and FluoroSpot Assays
Single-cell cytokine secretion profiling
These assays quantify the frequency of cytokine-secreting cells at the single-cell level.
ELISpot
-
Single cytokine per well
-
High sensitivity
FluoroSpot
-
Multiplex detection (two or more cytokines simultaneously)
-
Ideal for Th1/Th2/Th17 balance or polyfunctionality
Applications
-
Vaccine research
-
T cell memory studies
-
Autoimmunity and tolerance assessments
-
Functional immunology
Histology and Immunohistochemistry (IHC)
Tissue-level evaluation of morphology, infiltration, and biomarkers
Histology supports interpretation of in vivo and ex vivo findings by revealing tissue integrity, pathology, or immune infiltration.
Capabilities
-
Tissue processing and sectioning
-
H&E staining
-
IHC for cell types (e.g., CD3, F4/80) or biomarkers
-
Imaging and semi-quantitative scoring
Applications
-
In vivo model characterization
-
Mechanistic localization of immune responses
-
Tissue-level toxicity assessment
-
Biomarker validation
Sysmex Hematology
Hematological biomarker analysis and immune cell composition
Sysmex analysis provides quantitative assessment of:
-
RBC, WBC, platelet profiles
-
Differential leukocyte counts
-
Immune cell dynamics during disease
-
Hematological safety markers
Useful for:
-
In vivo model characterization
-
Toxicity studies
-
Treatment-response monitoring
Integrated Molecular Profiling at Redoxis
Redoxis combines multiple molecular readouts to generate a holistic view of therapeutic effects.
Examples of integrated workflows:
-
Flow cytometry + Luminex + RNA-seq for mechanistic depth
-
Histology + cytokine profiling for in vivo model validation
-
Phospho-signaling + qPCR to map drug activity
This multi-layered approach helps identify:
-
Pathway modulation
-
Mechanism of action
-
Predictive and pharmacodynamic biomarkers
-
Translational signatures relevant for clinical development
Why Use Molecular & Biomarker Applications at Redoxis?
-
Strong scientific expertise in immunology and inflammation
-
End-to-end molecular workflows (cell → tissue → RNA/protein → data)
-
High analytical sensitivity and reproducibility
-
Tailored biomarker panels for your disease area and modality
-
Integrated interpretation across technologies
